Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Completed Phase 3 Trials for Valspodar (DB11869)

IndicationStatusPhase
DBCOND0028534 (Adult Acute Minimally Differentiated Myeloid Leukemia (M0))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00006363Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid LeukemiaTreatment
NCT00003190Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid LeukemiaTreatment